Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Jan 24, 2024

SELL
$233.08 - $265.59 $41,721 - $47,540
-179 Reduced 13.36%
1,161 $288 Million
Q2 2023

Jan 24, 2024

SELL
$224.99 - $256.14 $12,374 - $14,087
-55 Reduced 3.94%
1,340 $322 Million
Q1 2023

Jan 24, 2024

SELL
$239.75 - $277.0 $479 - $554
-2 Reduced 0.14%
1,395 $352 Million
Q4 2022

Jan 19, 2024

BUY
$241.42 - $282.29 $8,208 - $9,597
34 Added 2.49%
1,397 $371 Million
Q3 2022

Jan 19, 2024

BUY
$247.06 - $1507.4 $131,188 - $800,429
531 Added 63.82%
1,363 $352 Million
Q2 2022

Jan 19, 2024

BUY
$237.11 - $299.66 $3,319 - $4,195
14 Added 1.71%
832 $211 Million
Q1 2022

Jan 19, 2024

BUY
$257.27 - $315.76 $25,727 - $31,576
100 Added 13.93%
818 $240 Million
Q4 2021

Jan 19, 2024

BUY
$292.08 - $329.01 $209,713 - $236,229
718 New
718 $236 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $177B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Cedrus LLC Portfolio

Follow Cedrus LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cedrus LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cedrus LLC with notifications on news.